Status:
COMPLETED
Evaluation of a Short Version Computerized Test for Processing Speed to Detect Cognitive Disorders in HIV+ Patients
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
HIV-1
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this prospective study is to evaluate the prevalence of neurocognitive impairments in HIV infected patients comparing patients with and without HAART. Recent studies have demonstrated...
Eligibility Criteria
Inclusion
- Patients infected with HIV-1
- Patients followed in outpatient service, over 18 years of age
Exclusion
- Patients infected with HIV-2
- Patients with difficulty understanding the French language
- Patients present with progressive opportunistic infection
- Patients for whom a change of psychotropic treatment was performed in the last 3 weeks
- Patients with drug and / or alcohol addiction
- Patients with a history of psychiatric disorder
- Patients with stroke, endocarditis or meningoencephalitis with severe neurological sequelae
Key Trial Info
Start Date :
March 16 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2018
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03279835
Start Date
March 16 2017
End Date
October 30 2018
Last Update
May 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Pasteur 2 - Service de Neurologie
Nice, France, 06001